New patient education videos available on the TUCC website

CLICK HERE to view the entire video series.

TUCC offers patients greater convenience with online patient portal

CLICK HERE for instructions on how to use the TUCC patient portal.

Issue 14Summer/Fall 2014

At TUCC, our mission is excellence in urology.

That commitment extends to providing our

patients with easy-to-access tools to manage their

urologic health and their relationship with us.

Our recently launched online patient portal provides patients with secure access to:

• Receive lab results and other messages from

TUCC physicians.

• View billing statements.

• Pay bills from TUCC. We accept debit cards,

Visa and Mastercard.

A wealth of patient education resources are posted

throughout The Urology Center of Colorado (TUCC)

website. In order to provide greater understanding

of the diagnostic and treatment options available for

various urologic conditions, we have created a new

online video series featuring interviews with several

TUCC physicians.

Topics covered include:

• Dr. Eric Gross: Targeted radiation therapy as a

treatment option for urologic cancers

• Dr. Jesse Mills: Men’s urologic health and the Center

for Men’s Health at TUCC

• Dr. Carsten Sorensen: Kidney and ureteral stones

• Dr. Eli Hsu: Female urologic health

• Dr. Mark Jones: Prostate

cancer screening and

robotic surgery

Issue 14Fall 2014

September is national Prostate Cancer Awareness

Month. More than 3,000 men in Colorado will be

diagnosed with prostate cancer this year. It’s a

disease that impacts our fathers, our husbands, our

brothers and our friends.

TUCC is well known throughout the Rocky

Mountain region as a prostate cancer treatment

center of excellence. In fact, we treat more

prostate cancer patients than any other facility

in Colorado. From diagnosis, to treatment, to

survivorship resources, we are committed to

providing patients with technologically advanced,

compassionate patient care.

Did you know?• TUCC utilizes on-site, intensity modulated

radiation therapy (IMRT), image guided radiation

therapy (IGRT), 3-D conformal planning and

prostate brachytherapy seed implantation for

patients diagnosed with prostate cancer. Our

radiation oncologist, Dr. Eric Gross, is the only

radiation oncologist in Colorado to devote his

practice solely to the treatment of urologic

cancers.

• TUCC surgeons lead the region in performing

da Vinci robotic prostatectomies (prostate

removal), having performed more than 3,000

over the past 10 years. Experience speaks

volumes. In 2013, HealthGrades ranked TUCC

and our hospital partner, Porter Adventist

Hospital, as one of the top 100 U.S. hospitals

for prostatectomies. This ranking is the result of

having the lowest surgical complication rate for

this procedure among all hospitals in the Rocky

Mountain region.

• Each month, the TUCC Tumor Board – made

up of physicians representing the disciplines of

urology, radiation oncology, medical oncology,

radiology and pathology - meets at TUCC to

analyze difficult prostate cancer cases. This

collaborative approach allows us to provide our

Why choose TUCC for prostate cancer treatment?

2

Find more about TUCC’s expertise in treating prostate cancer at www.tucc.com/prostatecancer.

continued on page 3

3

patients with comprehensive, multi-disciplinary

treatment options.

• There has been a lot of controversy surrounding

prostate cancer screening in recent years. At

TUCC, we believe that the Prostate Specific

Antigen (PSA) blood test remains an important

tool in the diagnosis of prostate cancer. Our

physicians follow the recommendations of the

American Urological Association in encouraging

men to have a baseline prostate cancer screening

at age 40. Because prostate cancer is a slow

growing disease, early detection is paramount.

An early stage prostate cancer diagnosis also

doesn’t necessarily require treatment. In many

instances, we will place a prostate cancer patient

on active surveillance and monitor his disease

over time before treatment is recommended.

Why choose TUCC for prostate cancer treatment?

Austin DeRosa, M.D.,

obtained his medical

doctorate from Tulane

University School

of Medicine. He

completed his surgical

internship and urologic

residency at Emory

University School

of Medicine before

receiving additional training as a minimally invasive

oncology fellow at the Medical University of South

Carolina. Dr. DeRosa’s specialties include:

• Robotic surgery for benign and cancerous

urologic disease

• Laparoscopic surgery

• Retroperitoneoscopic surgery

• Surgical management of kidney and ureteral

stones

Mina Lee, M.D.,

obtained her medical

doctorate from the

University of South

Florida School of

Medicine. She

completed her surgical

internship, surgical

residency and urologic

residency at the

University of Colorado Health Sciences Center.

Prior to joining TUCC, she practiced with Advanced

Urology and Kaiser Permanente. She is board

certified in urology. Dr. Lee’s specialties include:

• Female urology

• Female urinary incontinence

• Vaginal/pelvic organ prolapse

• Neurourology

• Urodynamic testing and interpretation

TUCC physician team expands

CLICK HERE to learn more about Dr. DeRosa and Dr. Lee as well as our entire team of 17 urologists and one radiation oncologist.

We are pleased to announce the addition of two urologists to our team of expert physicians.

continued from page 2

Mark your calendars and register online now for the 5th annual Blue Shoe Run for Prostate Cancer!

4

Visit www.TheBlueShoeRun.com to register for the fifth annual Blue Shoe Run for Prostate Cancer.

Run for your father, your husband, your brother,

your friend. Run for you! Join The Urology Center

of Colorado (TUCC) Foundation for the 5th annual

Blue Shoe Run for Prostate Cancer on Saturday,

September 13, 2014.

The Blue Shoe Run is TUCC Foundation’s signature

fundraising event. More than $275,000 has been

raised for the Foundation since 2010 as we work

to improve prostate cancer screening, community

education and research programs in the Rocky

Mountain region.

Prizes and awards will be given to the top three

male, female and prostate cancer survivor finishers

at The Blue Shoe Run. We will also recognize the

largest team with its own VIP tent on race-day and

our largest corporate team with a beautiful engraved

trophy to display on-site for an entire year!

Twelve hundred people joined us for the 2013 Blue

Shoe Run. Help us reach our goal of getting more

than 1,500 participants on the course to stomp out

prostate cancer on September 13!

see page 5 for schedule

Location:The Urology Center of Colorado

2777 Mile High Stadium Circle

Denver, CO 80211

Events:7:45 a.m. Kids Fun Run - Free

8:00 a.m. 5K Run/Walk

8:15 a.m. 1.5-Mile Family Walk

Post-Race Party:• Alaskan Brewery beer garden

• Food and drinks

• Prostate cancer survivor recognition

• Live music – on the course and during the post-

race party

• Silent auction - now in its 4th year!

• Kids zone – including face painting, games and a

giant inflatable slide!

• Educational, sponsor and vendor booths

5

Clinical research at TUCC The internationally recognized TUCC Clinical

Research Department participates in all phases

of clinical trials. At any given time, our highly

experienced staff may be enrolling patients in 10 to

20 different studies.

The TUCC Clinical Research Department is

recognized as:

• An appointed, certified site for the South West

Oncology Group to conduct bladder cancer clinical

trials.

• An appointed, certified site for the Radiation

Therapy Oncology Group to conduct prostate

cancer clinical trials.

• A member of the Society of Urologic Oncology

Clinical Trials Consortium. TUCC is one of only

22 large urology groups in the country with this

designation.

Through clinical research, we are able to offer

patients access to tomorrow’s urologic treatments

today. Participation in a clinical trial is safe and

voluntary. Study related medication and procedures

are provided at no cost.

CLICK HERE to learn more about our active, recruiting and active, non-recruiting clinical trials.

2014 Blue Shoe Run schedule

The TUCC Clinical Research Department with Director Lawrence Karsh, M.D.

6

Colorado primary care providers encouraged to attend the 2014 State-of-the-Art Symposium

On Saturday, October 18, 2014, TUCC will host the

fifth annual State-of-the-Art Symposium – Here Comes

the Boom: Geriatric Medicine and Evolving Health

Care Technology – in partnership with Colorado Heart

& Vascular, Rocky Mountain Gastroenterology and

Surgical Specialists of Colorado.

This FREE Symposium is an interactive, full-day

educational event specifically designed for physicians,

physician assistants, nurse practitioners and nurses.

Throughout the day, Symposium presenters will deliver

30-minute presentations on geriatric medicine and the

impact technology is having on health care delivery today.

Mark Moyad, M.D., director of complementary medicine

at the University of Michigan, will again serve as the

Annual Symposium keynote presenter, focusing on

nutrition and supplements. Michael Victoroff, M.D., will

close the Symposium with a COPIC update on the do’s

and don’ts of social media in health care.

8 CME credits, 7.50 AAFP credits, 8 CNE contact hours

and 2 COPIC ERS points will be offered to State-of-the-

Art Symposium attendees.

Event Details: Date: Saturday, October 18, 2014

Time: 7:30 a.m. – 4:00 p.m.

Where: PPA Event Center, 2105 Decatur Street

Denver, CO 80211

CLICK HERE to register for the 2014 State-of-the-Art Symposium.

Register today for Dr. Mark Moyad’s annual presentation on nutrition and supplements

TUCC is thrilled to welcome Dr. Mark Moyad,

directory of complementary medicine at the

University of Michigan, back to Denver for a

17th year on October 16. His premier update on

nutrition and supplements is a free seminar for

those interested in cancer prevention and those

living with cancer.

Dr. Moyad is the author of more than 130 medical

articles and 10 book chapters. He is the author or

co-author of 10 books including The Supplement

Handbook and Promoting Wellness for Prostate

Cancer and is the former editor-in-chief of the

medical journal Preventive and Alternative

Medicine.

Presentation Details: Date: Thursday, October 16, 2014

Time: 6:30 p.m.

Where: PPA Event Center

2105 Decatur Street

Denver, CO 80211

Visit www.tucc.com/supportgroups to register for Dr. Moyad’s presentation.